Apothecon is a research-led pharma company delivering niche APIs, peptides, and complex formulations under stringent global standards—making specialized, high-quality medicines accessible worldwide.
With regulatory approvals and trusted partners in 100+ countries, our medicines reach patients across continents, improving lives every day.
From molecule to market, our integrated capabilities span product development, global-grade manufacturing, and strategic partnerships — built to deliver precision, compliance, and scalability.
We specialize in complex molecules — including peptides, iron complexes, and chiral APIs — developed through innovative, non-infringing routes.
Our R&D teams design 505(b)(2) formulations, oral solids, injectables, and nasal sprays tailored for therapeutic precision and patient ease.
With USFDA, UK MHRA, WHO-GMP approved sites and SAP-powered controls, we deliver high-quality output at global regulatory standards.
Partner with us to scale your molecule — from technology transfer to commercial production — across APIs, oral solids, and complex formulations.
We specialize in complex molecules — including peptides, iron complexes, and chiral APIs — developed through innovative, non-infringing routes.
Our R&D teams design 505(b)(2) formulations, oral solids, injectables, and nasal sprays tailored for therapeutic precision and patient ease.
With USFDA, UK MHRA, WHO-GMP approved sites and SAP-powered controls, we deliver high-quality output at global regulatory standards.
Partner with us to scale your molecule — from technology transfer to commercial production — across APIs, oral solids, and complex formulations.
We specialize in complex molecules — including peptides, iron complexes, and chiral APIs — developed through innovative, non-infringing routes.
Our R&D teams design 505(b)(2) formulations, oral solids, injectables, and nasal sprays tailored for therapeutic precision and patient ease.
With USFDA, UK MHRA, WHO-GMP approved sites and SAP-powered controls, we deliver high-quality output at global regulatory standards.
Partner with us to scale your molecule — from technology transfer to commercial production — across APIs, oral solids, and complex formulations.
Our CSR initiatives focus on education, healthcare, and sustainability — investing in students, society, and the planet.
Discover our milestones, innovations, and global impact stories.
Visit Apothecon at CPHI 2025, Germany at worldwide 2025 at Hall 12.0 , Booth No. D86. Date - October 28-30,2025
Apothecon Pharma is launching a new mfg. facility at Sayakha, Gujarat, India with peptide facility and FDF facility with a capacity of 1 Billion Tablets / Capsules.
We got awarded for our groundbreaking innovation and contributions in developing distribution pathways for newly approved drugs targeting select Rare Diseases.
Visit Apothecon at CPHI 2025, Germany at worldwide 2025 at Hall 12.0 , Booth No. D86. Date - October 28-30,2025
Apothecon Pharma is launching a new mfg. facility at Sayakha, Gujarat, India with peptide facility and FDF facility with a capacity of 1 Billion Tablets / Capsules.
We got awarded for our groundbreaking innovation and contributions in developing distribution pathways for newly approved drugs targeting select Rare Diseases.
Visit Apothecon at CPHI 2025, Germany at worldwide 2025 at Hall 12.0 , Booth No. D86. Date - October 28-30,2025
Apothecon Pharma is launching a new mfg. facility at Sayakha, Gujarat, India with peptide facility and FDF facility with a capacity of 1 Billion Tablets / Capsules.
We got awarded for our groundbreaking innovation and contributions in developing distribution pathways for newly approved drugs targeting select Rare Diseases.
